|
Volumn 14, Issue 3, 2008, Pages 474-478
|
Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage
|
Author keywords
Alanyl glutamine dipeptide; Clinical study; Severe acute pancreatitis
|
Indexed keywords
ALANYLGLUTAMINE;
ACUTE HEPATITIS;
ACUTE PANCREATITIS;
ADULT;
AGED;
APACHE;
ARTICLE;
BRAIN DISEASE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMOGRAPHY;
DISEASE DURATION;
DISEASE SEVERITY;
FEMALE;
HOSPITALIZATION;
HUMAN;
INFECTION RATE;
KIDNEY FAILURE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
OUTCOME ASSESSMENT;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY DISTRESS;
SCORING SYSTEM;
SHOCK;
STOMACH PARESIS;
|
EID: 40049090690
PISSN: 10079327
EISSN: None
Source Type: Journal
DOI: 10.3748/wjg.14.474 Document Type: Article |
Times cited : (38)
|
References (42)
|